|
Grand Magnate
|
|
Join Date: Jan 2015
Location: Sydney, Australia.
Posts: 3,093
|
|
Grand Magnate
Join Date: Jan 2015
Location: Sydney, Australia.
Posts: 3,093
|
Thanks DejaVu - those results are impressive.
Targeting IL-23 (guselkumab) as well as/instead of TNF (adalimumab) looks like a good plan to me.
__________________
Knowledge is power.
|